Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection

• Sara Lodi ,

  * E-mail: slodi@hsph.harvard.edu

  Affiliation Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• Martin Fisher,

  Affiliation Brighton and Sussex University Hospitals National Health Service Trust, Brighton, United Kingdom

  ⨯
• Andrew Phillips,

  Affiliation University College of London, London, United Kingdom

  ⨯
• Andrea De Luca,

  Affiliation University Division of Infectious Diseases, University Hospital of Siena, Siena, Italy

  ⨯
• Jade Ghosn,

  Affiliation Université Paris Descartes, EA 3620, Paris, France

  ⨯
• Ruslan Malyuta,

  Affiliation Perinatal Prevention of AIDS Initiative, Odessa, The Ukraine

  ⨯
• Robert Zangerle,

  Affiliation Innsbruck Medical University, Innsbruck, Austria

  ⨯
• Santiago Moreno,

  Affiliation Hospital Ramon y Cajal, Madrid, Spain

  ⨯
• Philippe Vanhems,

  Affiliation Edouard Herriot Hospital, Lyon, and Universite' de Lyon 1, Lyon, France

  ⨯
• Faroudy Boufassa,

  Affiliation Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of HIV and STI Team, Le Kremlin-Bicetre, France

  ⨯
• Marguerite Guiguet,

  Affiliation INSERM and UPMC Univ Paris 06, UMR S 943, Paris, France

  ⨯
• Kholoud Porter,

  Affiliation MRC Clinical Trials Unit at University College London, London, United Kingdom

  ⨯
• for CASCADE Collaboration in EuroCoord

  ¶Membership of the CASCADE Collaboration is provided in the Acknowledgments.

  ⨯